- Home
- ACXP vs PIII Comparison
ACXP vs PIII Comparison
Compare ACXP & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACXP | PIII |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 13.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACXP | PIII |
|---|---|---|
| Price | $3.49 | $3.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $143.67 | $16.25 |
| AVG Volume (30 Days) | ★ 77.3K | 11.3K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.17 | $3.50 |
| 52 Week High | $25.00 | $14.50 |
Technical Indicators
Market Signals| Indicator | ACXP | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 20.91 |
| Support Level | $3.98 | $3.50 |
| Resistance Level | $3.63 | $5.20 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 18.86 | 5.70 |
Price Performance
Historical ComparisonAbout ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.